Neuraminidase inhibitor and cap-dependent endonuclease inhibitor

This page covers all Neuraminidase inhibitor and cap-dependent endonuclease inhibitor drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Neuraminidase and cap-dependent endonuclease.

Targets

Neuraminidase and cap-dependent endonuclease

Phase 3 pipeline (1)

• Ten-days oseltamivir + baloxavir marboxil · UMC Utrecht · Infectious Diseases
  Oseltamivir is a neuraminidase inhibitor that blocks the release of influenza virus from infected cells, while baloxavir marboxil is a cap-dependent endonuclease inhibitor that blocks viral replication.

Patent intelligence

• neuraminidase inhibitor and cap dependent endonuclease inhibitor patent landscape — aggregated cliff calendar, attackable patents, originator estates